Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP668563.RANBwcW7Lc_1wni6WxyHULLsz-Ap-gvSlld5gYULsMsao130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP668563.RANBwcW7Lc_1wni6WxyHULLsz-Ap-gvSlld5gYULsMsao130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP668563.RANBwcW7Lc_1wni6WxyHULLsz-Ap-gvSlld5gYULsMsao130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP668563.RANBwcW7Lc_1wni6WxyHULLsz-Ap-gvSlld5gYULsMsao130_provenance.
- NP668563.RANBwcW7Lc_1wni6WxyHULLsz-Ap-gvSlld5gYULsMsao130_assertion description "[Based on methylation in primary tumors compared to normal adjacent tissues, NKX2-5, CLSTN1, SPOCK2, SLC16A12, DPYS and NSE1 are candidate biomarkers for prostate cancer (methylation range 50%-85%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP668563.RANBwcW7Lc_1wni6WxyHULLsz-Ap-gvSlld5gYULsMsao130_provenance.
- NP668563.RANBwcW7Lc_1wni6WxyHULLsz-Ap-gvSlld5gYULsMsao130_assertion evidence source_evidence_literature NP668563.RANBwcW7Lc_1wni6WxyHULLsz-Ap-gvSlld5gYULsMsao130_provenance.
- NP668563.RANBwcW7Lc_1wni6WxyHULLsz-Ap-gvSlld5gYULsMsao130_assertion SIO_000772 18446232 NP668563.RANBwcW7Lc_1wni6WxyHULLsz-Ap-gvSlld5gYULsMsao130_provenance.
- NP668563.RANBwcW7Lc_1wni6WxyHULLsz-Ap-gvSlld5gYULsMsao130_assertion wasDerivedFrom befree-2016 NP668563.RANBwcW7Lc_1wni6WxyHULLsz-Ap-gvSlld5gYULsMsao130_provenance.
- NP668563.RANBwcW7Lc_1wni6WxyHULLsz-Ap-gvSlld5gYULsMsao130_assertion wasGeneratedBy ECO_0000203 NP668563.RANBwcW7Lc_1wni6WxyHULLsz-Ap-gvSlld5gYULsMsao130_provenance.
- befree-2016 importedOn "2016-02-19" NP668563.RANBwcW7Lc_1wni6WxyHULLsz-Ap-gvSlld5gYULsMsao130_provenance.